OZURDEX Trademark

Trademark Overview

On Monday, April 20, 2009, a trademark application was filed for OZURDEX with the United States Patent and Trademark Office. The USPTO has given the OZURDEX trademark a serial number of 77717722. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, April 29, 2020. This trademark is owned by Allergan, Inc.. The OZURDEX trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery devices in the nature of syringes sold filled with dexamethasone for use in the eyes
ozurdex

General Information

Serial Number77717722
Word MarkOZURDEX
Filing DateMonday, April 20, 2009
Status800 - REGISTERED AND RENEWED
Status DateWednesday, April 29, 2020
Registration Number3773304
Registration DateTuesday, April 6, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2009

Trademark Statements

Goods and ServicesDrug delivery devices in the nature of syringes sold filled with dexamethasone for use in the eyes
Pseudo MarkOZUR DEXAMETHASONE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 23, 2009
Primary Code005
First Use Anywhere DateThursday, April 30, 2009
First Use In Commerce DateTuesday, September 1, 2009

Trademark Owner History

Party NameAllergan, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612
Party NameAllergan, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Trademark Events

Event DateEvent Description
Wednesday, April 29, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, April 29, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, April 29, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, April 28, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 26, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, April 6, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, May 1, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, May 1, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, May 1, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 20, 2015TEAS SECTION 8 & 15 RECEIVED
Monday, April 20, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 6, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 6, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, March 3, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, March 3, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 25, 2010STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 20, 2010USE AMENDMENT FILED
Thursday, February 25, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 20, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, November 3, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2009PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2009NOTICE OF PUBLICATION
Thursday, July 9, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 9, 2009ASSIGNED TO LIE
Monday, June 29, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 29, 2009EXAMINER'S AMENDMENT ENTERED
Monday, June 29, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 29, 2009EXAMINERS AMENDMENT E-MAILED
Monday, June 29, 2009EXAMINERS AMENDMENT -WRITTEN
Sunday, June 28, 2009ASSIGNED TO EXAMINER
Friday, April 24, 2009NOTICE OF PSEUDO MARK MAILED
Thursday, April 23, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 23, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

ozurdex filled dexamethasone eyes sold syringes delivery devices nature drug